We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+16.45%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$157M
AUM Growth
+$19.3M
Cap. Flow
+$6.96M
Cap. Flow %
4.45%
Top 10 Hldgs %
59.23%
Holding
147
New
34
Increased
35
Reduced
16
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 36.93%
2 Healthcare 27.25%
3 Financials 7.02%
4 Consumer Discretionary 4.71%
5 Communication Services 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMGN
76
DELISTED
Immunogen Inc
IMGN
$143K 0.09%
22,100
-4,700
-18% -$27.4K
BMY.RT
77
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$124K 0.08%
+180,400
New +$384K
SRNE
78
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$123K 0.08%
18,000
SYRS
79
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$119K 0.08%
+1,100
New +$100K
CDMO
80
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$119K 0.08%
10,300
MTRX icon
81
Matrix Service
MTRX
$330M
$116K 0.07%
+10,500
New +$96.8K
NPTN
82
DELISTED
NEOPHOTONICS CORP
NPTN
$115K 0.07%
12,700
CNSL
83
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$107K 0.07%
+21,900
New +$115K
ATEN icon
84
A10 Networks
ATEN
$1.97B
$106K 0.07%
10,700
AFMD
85
DELISTED
Affimed
AFMD
$105K 0.07%
1,804
-616
-25% -$29K
SEI
86
Solaris Energy Infrastructure
SEI
$3.87B
$101K 0.06%
+12,404
New +$88.6K
CMRX
87
DELISTED
Chimerix, Inc.
CMRX
$100K 0.06%
+20,767
New +$75.3K
KDMN
88
DELISTED
Kadmon Holdings, Inc.
KDMN
$98K 0.06%
23,700
UTI icon
89
Universal Technical Institute
UTI
$1.4B
$96K 0.06%
14,793
-507
-3% -$2.9K
OVID icon
90
Ovid Therapeutics
OVID
$482M
$95K 0.06%
+40,920
New +$191K
TRUE
91
DELISTED
TrueCar
TRUE
$94K 0.06%
22,400
-7,300
-25% -$32.5K
VRA icon
92
Vera Bradley
VRA
$95M
$93K 0.06%
11,737
-11,363
-49% -$86K
SURF
93
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$93K 0.06%
10,100
-3,900
-28% -$33.9K
LYTS icon
94
LSI Industries
LYTS
$907M
$92K 0.06%
10,800
PCTI
95
DELISTED
PCTEL, Inc. Common Stock
PCTI
$92K 0.06%
+14,000
New +$84.7K
ASMB icon
96
Assembly Biosciences
ASMB
$540M
$90K 0.06%
1,239
-985
-44% -$116K
APTX
97
DELISTED
Aptinyx Inc. Common Stock
APTX
$90K 0.06%
26,000
ALSK
98
DELISTED
Alaska Communications Systems
ALSK
$90K 0.06%
+24,447
New +$69.7K
ARAY icon
99
Accuray
ARAY
$34.6M
$87K 0.06%
20,938
-7,362
-26% -$27K
LINC icon
100
Lincoln Educational Services
LINC
$964M
$82K 0.05%
+12,541
New +$74.3K

Similar funds

HighVista Strategies's Q4 2020 Portfolio in Review

As of Q4 2020, HighVista Strategies held 147 positions worth $157M, up 14% from $137M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

HighVista Strategies deployed $6.96M of net new capital in Q4 2020, opening 34 new positions and adding to 35 existing holdings. Its largest new stake was DouYu International Holdings: 24,960 shares worth $2.76M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 37% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $1.25M trimmed.

  • HighVista Strategies's largest Q4 2020 buy was DouYu International Holdings: 24,960 shares worth $2.76M.
  • HighVista Strategies added most to Adaptimmune Therapeutics in Q4 2020, an estimated $564K increase.
  • HighVista Strategies's biggest Q4 2020 reduction was Alibaba, cutting an estimated $1.25M.
  • HighVista Strategies fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $7.15M.
  • HighVista Strategies's ten largest holdings make up 59% of its $157M portfolio in Q4 2020.
  • HighVista Strategies opened 34 new positions and closed 30 in Q4 2020.
  • HighVista Strategies's portfolio value rose 14% quarter-over-quarter to $157M.

Based on HighVista Strategies's 13F filing for Q4 2020, filed 16 Feb 2021.